Biotechnology startup Sirtris Pharmaceuticals said last week that Paul Schimmel and Christoph Westphal have joined its board of directors.
Schimmel is a faculty member of the Scripps Institute, a member of the National Academy of Sciences, and a cofounder of Alnylam Pharmaceuticals. He holds a PhD from the Massachusetts Institute of Technology.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
